QPP: Protease that Prevents Apoptosis in Quiescent Cells
QPP:防止静止细胞凋亡的蛋白酶
基本信息
- 批准号:7162147
- 负责人:
- 金额:$ 30.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:Activated LymphocyteActive SitesAffinityApoptosisBiological AssayCell CycleCell DeathCellsChromatographyCleaved cellCollaborationsDipeptidasesDipeptidesDominant-Negative MutationEmbryoEndopeptidasesEnhancersEnzymesEukaryotic CellGene ChipsGene SilencingGenesGenetic TranscriptionGenomeGenomicsGoalsHalf-LifeHumanImmune systemIn SituIn VitroIndividualInduction of ApoptosisInterphase CellIntronsLeadLibrariesLinkLymphocyteMapsMediatingMonitorMusMutant Strains MiceN-terminalNeuronsOrganPeptide HydrolasesPeptidesPhenotypePhysiologicalPlanet MarsProcessProlineProteinsRegulationReporterRestReverse Transcriptase Polymerase Chain ReactionRoleSTAT5A geneSequence AnalysisSiteSpecificityStructureSystemTP53 geneTamoxifenTestingTimeTissuesTransfectionTransgenic MiceUp-Regulationc-myc Genescell typecombinatorialembryonic stem cellenzyme activitygel electrophoresishomologous recombinationin vivomembrane dipeptidasemutantnovelpreventprogramspromoterreceptorrecombinaseresearch studytranscription factortransmission process
项目摘要
QPP (Quiescent cell _.Proline di-_Peptidase), also termed DPP2/7, is a vesicular protease that cleaves di-
peptides from the N-terminus of proteins, thereby impacting their half-life and/or receptor specificity.
While the full functional profile of this enzyme is far from understood, in vitro experiments demonstrate
that QPP is a major regulator of the Go quiescence program in primary lymphocytes and neuronal cells.
The primary objective of this renewal application is to analyze the mechanism of QPP-mediated survival
in resting lymphocytes. Aim I: The most direct approach to define the functional role of QPP is to
generate a mutant mouse deficient in QPP. Since previous attempts to derive conventional QPP# mice
were curbed by embryonic lethality, we propose a novel alternative to generate the mutant mouse,
utilizing the Cre/IoxP recombinase system that allows conditional and inducible genome alterations.
Aim I1" Inhibition of QPP advances quiescent lymphocytes into cell cycle, leading to upregulation of c-
Myc and p53 and finally apoptosis induction. Thus, it is postulated that QPP enzyme activity is required
for maintaining the Go program. To test this hypothesis, the control of expression and mechanism of
action of QPP will be delineated. Special emphasis will be given to LKLF and STAT5, two transcription
factors that are implicated in positive and negative regulation of QPP expression, respectively.
Furthermore, the role of c-Myc and p53 in the apoptosis pathway will be analyzed. Aim II1: To fully
understand the Go survival program in eukaryotic cells, it is essential to define the physiological
substrate(s) of QPP. Since this is the most ambitious project, various approaches will be used to reach
this goal, including the screen of combinatorial dipeptide substrate libraries, the structural comparison of
human and murine QPP with that of DPP4, and the isolation of a physiological substrate(s) by affinity
matrix chromatography. Collectively, these studies will augment our limited understanding of the
constitutive Go survival program in eukaryotic cells.
QPP(Quiescent cell _Proline di_Peptidase),也称为DPP 2/7,是一种切割二-脯氨酸的囊泡蛋白酶。
从蛋白质的N-末端的肽,从而影响它们的半衰期和/或受体特异性。
虽然这种酶的完整功能概况还远未了解,但体外实验表明,
QPP是初级淋巴细胞和神经元细胞中Go静止程序的主要调节剂。
本次更新申请的主要目的是分析QPP介导的存活机制
在静止的淋巴细胞中。目的一:界定品质专业计划职能的最直接方法是
产生QPP缺陷的突变小鼠。由于先前尝试获得常规QPP#小鼠
受到胚胎致死性的抑制,我们提出了一种新的替代方法来产生突变小鼠,
利用允许条件性和诱导性基因组改变的Cre/IoxP重组酶系统。
抑制QPP可使静止淋巴细胞进入细胞周期,导致c-
Myc和p53以及最后的凋亡诱导。因此,假定需要QPP酶活性
来维护围棋程序为了验证这一假设,我们研究了对基因表达的控制和基因表达的机制。
将描述QPP的作用。特别强调将给予LKLF和STAT 5,两个转录
分别涉及QPP表达的正性和负性调节的因子。
此外,c-Myc和p53在凋亡途径中的作用将被分析。目标二1:充分
为了了解真核细胞中的Go生存程序,定义生理学上的
QPP的底物。由于这是最雄心勃勃的项目,将采用各种方法来实现
这一目标,包括筛选组合二肽底物库,
人和鼠QPP与DPP 4的同源性,以及通过亲和层析分离生理底物
基质色谱法总的来说,这些研究将增加我们对
真核细胞中的组成型Go生存程序。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Th17 differentiation is the default program for DPP2-deficient T-cell differentiation.
- DOI:10.1002/eji.201041157
- 发表时间:2011-06
- 期刊:
- 影响因子:5.4
- 作者:Mele, Deanna A.;Sampson, James F.;Huber, Brigitte T.
- 通讯作者:Huber, Brigitte T.
Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing.
Bcl-x 的生物学独特构象可以使用 2D 等电聚焦来解析。
- DOI:10.1016/j.molimm.2009.02.031
- 发表时间:2009
- 期刊:
- 影响因子:3.6
- 作者:Rockwell,KarenR;Huber,BrigitteT
- 通讯作者:Huber,BrigitteT
Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review.
氨基二肽酶抑制剂诱导的静止淋巴细胞细胞死亡:综述。
- DOI:10.1023/a:1009675223443
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Chiravuri,M;Huber,BT
- 通讯作者:Huber,BT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brigitte T. Huber其他文献
Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules
细菌和内源性逆转录病毒超抗原的结合位点可以在主要组织相容性复合物 II 类分子上解离
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:15.3
- 作者:
Jacques Thibodeau;Nathalie Labrecque;François Denis;Brigitte T. Huber;Rafick - 通讯作者:
Rafick
Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice
Mls 基因与近交系小鼠内源性乳腺肿瘤病毒的连锁
- DOI:
10.1038/349526a0 - 发表时间:
1991-02-07 - 期刊:
- 影响因子:48.500
- 作者:
Wayne N. Frankel;Christine Rudy;John M. Coffin;Brigitte T. Huber - 通讯作者:
Brigitte T. Huber
Molecular characterization of Mls-1.
Mls-1 的分子表征。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:5
- 作者:
Ulrich Beutner;Christine Rudy;Brigitte T. Huber - 通讯作者:
Brigitte T. Huber
Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
II 类 MHC 产物和 Tcrb-V8.2 等位基因控制大鼠 T 细胞对逆转录病毒和细菌超抗原的反应。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:4.4
- 作者:
Thomas Herrmann;T. Hochgrebe;N. Torres;Brigitte T. Huber;T. Hünig - 通讯作者:
T. Hünig
Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.
NZB 小鼠自发性过度活跃 B 细胞定位于特定 B 细胞亚群。
- DOI:
- 发表时间:
1979 - 期刊:
- 影响因子:11.1
- 作者:
Pamela B. Nakajima;S. K. Datta;Robert S. Schwartz;Brigitte T. Huber - 通讯作者:
Brigitte T. Huber
Brigitte T. Huber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brigitte T. Huber', 18)}}的其他基金
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
下丘脑 VMN 中 DPP2 底物的鉴定
- 批准号:
8365792 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
下丘脑 VMN 中 DPP2 底物的鉴定
- 批准号:
8171443 - 财政年份:2010
- 资助金额:
$ 30.06万 - 项目类别:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
耐药性莱姆关节炎自身抗原的鉴定
- 批准号:
7723039 - 财政年份:2008
- 资助金额:
$ 30.06万 - 项目类别:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
慢性莱姆关节炎滑膜病变自身抗体的靶点
- 批准号:
7723069 - 财政年份:2008
- 资助金额:
$ 30.06万 - 项目类别:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
慢性莱姆关节炎滑膜病变自身抗体的靶点
- 批准号:
7602063 - 财政年份:2007
- 资助金额:
$ 30.06万 - 项目类别:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
耐药性莱姆关节炎自身抗原的鉴定
- 批准号:
7602033 - 财政年份:2007
- 资助金额:
$ 30.06万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 30.06万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 30.06万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 30.06万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 30.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 30.06万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 30.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 30.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 30.06万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 30.06万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 30.06万 - 项目类别:
Discovery Grants Program - Individual